Risk Factors for Denosumab Discontinuation in Patients with Postmenopausal Osteoporosis.
Sign Up to like & getrecommendations! Published in 2022 at "Modern rheumatology"
DOI: 10.1093/mr/roac070
Abstract: OBJECTIVES Persistence with treatment is key to achieving successful treatment outcomes in patients with osteoporosis. We investigated risk factors for denosumab discontinuation in patients with postmenopausal osteoporosis (PMO). METHODS A total of 333 patients with… read more here.
Keywords: factors denosumab; denosumab discontinuation; risk factors; discontinuation patients ... See more keywords